General Biotechnology

RNAi Firms Stake Their Claims First there was gene splicing. Next came monoclonal antibodies. And now, RNA interference, or gene […]

More U.S. Investment in Biotech Needed, USAID Chief Says The United States and the international community should continue to invest

Wake Up and Smell the Science Longer-Lasting Perfume Is One Promise As Biotechnology Heads for Store Shelves

Biotech Investors: When Will They Ever Learn? Investors should get a grip on reality. Many small companies that were lifted

Drug ads deliver a few side effects Drug companies tripled their advertising budgets in recent years to acquaint American consumers

Biotech Industry Could Turn Profitable This Decade The U.S. biotechnology industry could turn a net profit within five to seven

Biotech firms eye rally hungrily With so many firms in dire financial straits, many executives are desperately hoping that this

Biotech Stock Report – WOW! The market has gotten ahead of itself by chasing stories, but there is, in fact,

Schering-Plough: Drugmaker, Heal Thyself It has a potential blockbuster and a savvy new CEO. With federal probers and Claritin’s expired

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said